CORRESP 1 filename1.htm

 

 

June 28, 2018

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

 

Re: InspireMD, Inc.

 

Registration Statement on Form S-1 (Registration No. 333-225680), as amended - Concurrence in Acceleration Request

 

Ladies and Gentlemen:

 

H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the referenced offering, hereby concurs in the request by InspireMD, Inc. that the effective date of the above-referenced registration statement be accelerated to 12:00 P.M. (Eastern Time), or as soon as practicable thereafter, on June 29, 2018, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.

 

  Very truly yours,
     
  H.C. WAINWRIGHT & CO., LLC
     
  By: /s/ Mark W. Viklund
  Name: Mark W. Viklund
  Title: Chief Executive Officer